Halozyme Therapeutics (HALO) Other Non-Current Assets (2009 - 2026)
Halozyme Therapeutics (HALO) posted Other Non-Current Assets of $55.09 million for Q2 2026, up 8.2% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics' Other Non-Current Assets came in at $53.55 million, down 33.6% from FY2024.
- Annual Other Non-Current Assets shows a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Other Non-Current Assets was $80.6 million in FY2024, $26.3 million in FY2022 (+96.1%) and $13.41 million in FY2021 (-4.6%).
- Quarterly Other Non-Current Assets has run from a low of $13.41 million in Q4 2021 to a high of $80.6 million in Q4 2024 over five years.
- The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q3 2024, with growth of 342.5%; the weakest was Q4 2025, with a decline of 33.6%.
- According to Business Quant data, Other Non-Current Assets for the three prior quarters was $50.92 million (Q1 2026), $53.55 million (Q4 2025) and $55.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn | 121.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 121.21 Mn |
| Jun 30, 2026 | 73.61 Mn |
| Mar 31, 2026 | 68.50 Mn |
| Dec 31, 2025 | 67.09 Mn |
| Dec 31, 2024 | 98.00 Mn |
| Sep 30, 2024 | 96.72 Mn |
| Jun 30, 2024 | 73.79 Mn |
| Mar 31, 2024 | 30.27 Mn |
| Sep 30, 2023 | 30.92 Mn |
| Jun 30, 2023 | 24.23 Mn |
| Mar 31, 2023 | 33.16 Mn |
| Dec 31, 2022 | 41.79 Mn |
| Sep 30, 2022 | 36.63 Mn |
| Jun 30, 2022 | 33.63 Mn |
| Mar 31, 2022 | 24.61 Mn |
| Dec 31, 2021 | 16.01 Mn |
| Sep 30, 2021 | 18.43 Mn |
| Jun 30, 2021 | 18.57 Mn |
| Mar 31, 2021 | 16.36 Mn |
| Dec 31, 2020 | 19.35 Mn |
API Access
Halozyme Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();